Randomised controlled clinical control study to evaluate the efficacy of erandmool arka in udavarta yonivyapad with special refference to primary dysmenorrhoea
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- reduce pain before menses and during menses
研究概览
简要总结
Topic Randomised control clinical trial to study the efficacy of erandmool arka in udavarta yonivyapad with special reference to primary dysmenorrhoea
Materials and methods
There will be two groups as control group A and trial group B group A will be given mefenamic acid 250mg bd for 3 days and group B will be given erandmool arka 10 bd with koshna jal for 7 days before menses and follow up will be taken on fifth day of three consecutive menstrual cycle
Assessment criteria
Assessment will be done on what percentage of pain level will be reduced result and inference will be drawn on data collected by above methods
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 30.00 Year(s)（—）
- 性别
- Female
入选标准
- •clinically diagnosed cases of udavarta yonivyapad will be taken for study patient coming with chief complaints of painful menses suffering for at least 3 consecutive menstrual cycles patients with regular menstrual cycles and adequate menstrual flow not associated with any organic reproductive system abnormalities patients ready to participate in study with proper consent.
排除标准
- •patient having secondary dysmenorrhea patient age below 15 year and above 30 year anc and pnc patient patient on harmonal therapy or using an IUCD patient having any uterine or pelvic pathology patient with history of hypo/hyperthyroidism DM cardiovascular diseases.
结局指标
主要结局
reduce pain before menses and during menses
时间窗: reduce pain before menses and reduce symptoms of udavartini yonivyapd
次要结局
- no recurrence of symptoms of udavartini yonivyapad(21 days)
研究者
Dr Dhanashri Devendra Shrikhande
Shree Sapatashrhungi Ayurved Mahavidyalay